Introduction 51
Globally important diseases such as Dengue and Influenza spread across populations 52 as epidemics. While strain-specific immunity can be induced by vaccination or 53 infection, the continuing appearance of variant viruses presents a major challenge to 54 vaccine design. 55 56 Foreign antigens stimulate the formation of memory B-cells that have undergone 57 somatic hyper-mutation (SHM) of their antibody genes followed by selection in 58 germinal centres (GCs) for antibody affinity maturation (MacLennan et al. 1997 ). In 59 this manner protective immunity is established against subsequent exposure to 60 identical pathogens. What is poorly understood, but critical for the understanding of 61 immune responses to mutable pathogens, is how memory B-cells respond to variant 62 antigens. 63
64
We have recently shown that antibody memory responses to variant/heterotypic 65 Dengue envelope proteins involve secondary germinal centres (GCs) with a higher 66 proportion of IgM+ B-cells that have fewer VH mutations (Burton et al. 2018 ) 67 compared to the memory response to the homotypic antigen. These observations 68 provide support for the long speculated idea that 'lower' layers of the B-cell memory 69 compartment, with less SHM, could furnish secondary responses against variant 70 antigens, as the antibodies may be more tolerant of antigenic variation (Herzenberg et 71 al., 1980; Pape et al., 2011; Kaji et al., 2012) . however, is that immune responses to the second virus can be compromised, through 75 a process sometimes termed original antigenic sin (Francis, 1960) or antigenic 76 seniority (Henry et al. 2018) . We use the abbreviation AS for both. 77 78 In AS, cross-reactive memory-derived antibodies are induced which have a lower 79 avidity, and may increase pathology, as they are non-neutralising or enhance 80 infectivity (Halstead et al. 1977 , Halstead et al. 1983 , Kim et al. 2009 , Midgley et al. 81 2011 . Such effects of AS may facilitate Dengue epidemics (Adams et al. 2006 ), could 82 enhance Zika pathogenesis in Dengue endemic areas (Bardina et al. 2017 ) and may be 83 induced by vaccination (Screaton et al. 2015) . 84
85
While it is not surprising that a similar antigen induces a cross-reactive memory 86 response rather than a naïve response, due to increased numbers of memory cells and 87 their lower activation thresholds (Good et al. 2007 , Good et al. 2009 ), a critical 88 question in AS is why such memory responses then fail to rapidly evolve higher 89 affinity to variant antigens through a secondary GC reaction, mitigating pathogenesis. 90
91
There is a theoretical model that addresses this question (Deem et al. 2003) . It predicts 92 that over certain antigenic differences, antibody memory responses to a variant 93 antigen are worse than a primary response; i.e., that memory responses can be 94 compromised in their ability to evolve toward certain antigens. Using sequential 95 immunization with variant Influenza haemagglutinins and analysis of serum and GC 96 responses, we have tested predictions of this hypothesis and provide evidence that it is 97 correct. We show that an inefficient secondary response to a variant haemagglutinin is 98 associated with recruitment of highly mutated memory B-cells to the GC, altered 99 patterns of SHM, collapse of the GC reaction and poor serum avidity improvements. 100
Results 126
Primary and secondary response to PR8 HA 127
Firstly we sought to define the serum and GC response after homotypic antigen prime 128 and boost. Mice were primed with PR8/34 (PR8) HA1 with adjuvant and boosted 38 129 days later with soluble PR8 HA (see Methods for explanation of rationale). 130 131 PR8 HA1 priming induced an anti-PR8 HA IgG titre by day 17, increasing to day 44 132 ( Figure 1A) . Boosting increased the titre modestly (by two-fold) but significantly by 133 day 17 post boost. 134 135 Time points were chosen to assess recent recruits to GCs (day 6) and then after 136 selection had been established (day 17) (Victora 2014 ). Levels of GC B-cells rose 137 from a background of 0.18% to 0.75% by day 6 after priming, remained elevated to 138 day 17, and fell to background by day 44 (Figure 1 B, C). Boosting induced GC B-139 cells to a higher level: 1.5%, by day 6, which reduced but not significantly by day 17 140 ( Figure 1C ). 141 142 VH mutations increased by day 17 after priming, consistent with active SHM and 143 affinity maturation ( Figure 1D ). Boosting induced GC B-cells with a higher level of 144 VH mutation at day 6 (median=3) than seen at day 6 after priming (median=1.5), 145 consistent with a response mostly from memory B-cells focused on the HA1 head 146 region. GC B-cells then accumulated further mutations by day 17 after boost 147 (median=6), consistent with further affinity maturation. Analysis of the relative avidity of serum IgG ( Figure 1E ) showed a rapid increase by 163 day 6 after PR8 HA boosting, consistent with preferential stimulation of the highest 164 affinity memory cells by the homotypic boost, and the subsequent immediate 165 differentiation of many of them into antibody-secreting cells. There was no detectable 166 avidity increase by day 17 but a further increase was detected by day 30. antigen, we performed a homotypic Bris59 HA1/Bris59 HA prime-boost. We also did 212 the reverse heterotypic Bris59 HA1/PR8 HA prime-boost. The homotypic Bris59 213 prime-boost induced similar levels of early GC B-cells (1.2%; Figure 2E ) to the 214 homotypic PR8 prime-boost (1.5%; Figure 1C ), which then declined slightly by day 215 17 to 0.7%, and two-fold higher serum IgG titres ( Figure 3A ) compared to the 216 homotypic PR8 prime-boost ( Figure 1A ), suggesting its antigenicity is similar and not 217 explaining the drop in GC B-cell levels after the heterotypic PR8 HA1/Bris59 HA 218 prime-boost. Interestingly, the reverse heterotypic Bris59 HA1/PR8 HA boost did not 219 induce high levels of early GC B-cells ( Figure 2F Figure 3B ). At day 30, however, the IgG titre was only slightly more in adjuvanted 236
Bris59 HA boosted mice compared to Bris59 HA primed mice ( Figure 3A) . 237
Considering pre-existing IgG titre prior toBris59 HA boosting, the increase in titre 238 may be less. Figure 2C) , implying 259 that no extra naïve, or naïve-like memory cells, were recruited to GCs by adjuvant. By 260 day 17 median VH mutations in this group had only increased by one ( Figure 3C) . 261 GC B-cells 6 days after Bris59 HA priming had lower levels of VH mutation 262 (median=2), consistent with a primary response. 263
264
The adjuvanted Bris59 HA boost induced a significant increase in serum avidity from 265 day 6 to day 30, but only to levels comparable to those seen with the Bris59 HA 266 prime group, being 54% vs. 51%, and not approaching the avidity of the homotypic 267 Bris59 HA1/Bris59 HA prime-boost which was 72% ( Figure 3D ). Considering the 268 net level of increase in avidity between day 6 and day 30, the Bris59 HA prime 269 appeared more efficient (41% increase) than the adjuvanted heterotypic boost (28% 270 increase). HA and the heterotypic Dengue protein E4 and E2 responses all showed increases in 280
IgM VH mutation of between +1.5 and +4.5 as the GC response matured ( Figure 3E) . 281
In the adjuvanted Bris59 HA boost response there was no increase in IgM mutations 282 and the largest increase in IgG mutations between day 6 and day 17. (Figures 2B, 3C ). In the adjuvanted Bris59 320 HA boost the higher levels of mutation in IgM at day 6 then failed to increase further 321 during the mutation and selection process to day 17 ( Figure 3E ). We propose that 322 these heterotypic secondary responses to Bris59 HA were compromised because 323 antibody evolvability was reduced. This could be due either to an intrinsic loss of 324 evolvability in mutated V genes, other constraints in the memory antibody repertoire, 325 or for GC dynamical reasons such as increased SHM and class switching affecting 326 GC B-cell longevity and fate (Gitlin et al. 2016) . 327
328
The model of Deem and Lee (Deem et al. 2003 ) provides both a hypothesis for AS, 329
and for heterotypic memory responses in general. By modeling the evolution of 330 memory-derived antibodies, they predict that over a certain window of antigenic 331 difference, memory responses to variant antigens can be worse than primary 332 responses to the same antigen due to constraints in the antibody fitness landscape. 333 This is despite memory B-cells initiating with a higher affinity than naïve cells for 334 variant antigen, which also explains their dominance of the recall response. If 335 antibody evolvability was lost, memory B-cells would be recruited to GCs, SHM 336 would occur, but the GC reaction and affinity maturation would fail. This is what we 337 observe with the non-adjuvanted Bris59 HA boost. 338 339
The Deem model assumes that any memory B-cells stimulated by homotypic and 340 heterotypic boosts are equally mutated. It seems the HA1 region of the Bris 59 HA 341 protein was sufficiently similar to PR8 HA1 (82%) to do this and induce the most 342 mutated, and more often class-switched, anti-PR8 HA1 memory cells, which were 343 then inefficient at further improving affinity for Bris 59 HA. This contrasts, in 344 particular, with the Dengue E3 Prime/E4 boost response, where the antigen pair were 345 only 63% identical and the secondary GC were dominated by IgM+ B-cells with very 346 few mutations that then provided for efficient further affinity maturation (Burton et al. HA boost response, that shows a persisting GC reaction, there is a low overall 360 increase in SHM of +1 ( Figure 3C ) compared to +3 in the non-adjuvanted homotypic 361 boost ( Figure 1D) , with no increase in IgM mutations but the largest increase in IgG 362 mutations, between day 6 and day 17 ( Figure 3E ). If beneficial mutations are very 363 rare, then most mutations will result in cell death, so extra mutation levels may be 364 lower, as we observe overall, and also in the IgM+ population. Finally, if an increased 365 number of mutations is necessary to circumvent the constraints of the antibody fitness 366 landscape, successfully selected cells would be expected to have a greater increase in 367 mutation, and this is what we observe in the IgG+ pool between day 6 and day 17. 368
369
There are also other reasons why mutated memory antibodies may be less evolvable. 370
They could have lost hotspots for the aicd mutator, lost codons predisposed to non-371 conservative substitutions (Hershberg and Shlomchik 2006) and despite being diverse 372 at the sequence level may be more restricted in V-gene diversity so have more 373 constrained evolutionary trajectories. 374
The inefficient response to Bris59 HA could be due to reduced T-cell help for variant 376 antigens. T-cell help is necessary for memory B-cell responses to viral proteins 377 (Hebeis et al. 2004 ), so the robust early GC response to Bris59 HA boosting shows 378 that help was not impaired at this point. Further, we have shown with heterotypic 379
Dengue proteins with only 63% sequence homology, that in vitro T-cell re-380 stimulation was as efficient as with the homotypic protein (Burton et al. 2018) , 381 demonstrating that antigens with large overall sequence differences can still 382 efficiently stimulate memory T-cells. The PR8/Bris59 HA1 sequence homology is 383 82% so we do not consider reduced T-cell help was a major factor here. The response 384
to Bris boosting with adjuvant, with robust and sustained GC activity, also supports 385 this conclusion. 386
387
That certain antibody memory responses can have reduced efficiency has important 388 implications for understanding viral disease pathogenesis. It is plausible that epidemic 389 strains of virus could appear with the appropriate degrees of antigenic difference to 390 exploit this phenomenon, as has been previously modeled (Adams et al. 2006) . Three mice were randomly allocated to cages. For greater sample sizes treatments 448 were independently replicated. Where t-test was applied, data points were analysed 449 for equality of variance, and where violated were subject to a two-tailed test for 450 unequal variance, otherwise a two-tailed test for equal variance. 451 452 453 454
Acknowledgements 455
We are grateful to the late Michael Neuberger for early critical discussions. Thanks to 456
Patrick Wilson and Christian Busse for advice on single cell antibody PCR and James 457
Cresswell for advice on statistics .  458   459   460   461   462  463  464  465  466  467  468  469  470  471  472  473  474  475  476  477  478  479  480  481  482  483  484  485  486  487 
